Dr. Lingxiao Liu 刘凌晓
Chief Physician, Associate Professor
Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiofrequency and microwave ablation for benign thyroid and breast tumors; minimally invasive treatment for liver and lung tumors; management of obstructive jaundice, portal vein thrombosis, DVT, pulmonary embolism, Budd-Chiari syndrome, and cirrhosis complications.
Dr. Liu is a Chief Physician and Associate Professor, and a master’s supervisor. Dr. Liu holds a joint clinical doctorate from Fudan University and the University of Hong Kong. Dr. Liu has led one National Natural Science Youth Fund project and two provincial-level research projects, and published over 10 academic papers.
Name order: in Chinese the family name comes first (Liu Lingxiao). Papers usually list the name as Lingxiao Liu or Liu L.
Selected publications
70 papers on PubMed matched by name and affiliation; 15 as first or senior author since 2016. Most recent first- or senior-author papers:
- Lung Cancer, 2026 (senior author): Dynamic contrast-enhanced and intravoxel incoherent motion magnetic resonance imaging to assess early response of microwave ablation in lung tumors. PubMed 42127536
- J Cancer Res Ther, 2026 (senior author): Advancements in selective internal radiotherapy: Efficacy, safety, and future directions. PubMed 42241154
- J Cancer Res Ther, 2026 (senior author): Cone-beam CT-guided thermal ablation vs video-assisted thoracic surgery in treatment of non-small-cell lung cancer: A propensity score matching analysis. PubMed 42041238
- Brachytherapy, 2025 (senior author): Intraluminal brachytherapy using (125)I seed strand combined with PTBD and Hepatic arterial infusion chemotherapy for unresectable Bismuth-Corlette III and IV stage hilar cholangiocarcinoma. PubMed 40050186
- J Clin Endocrinol Metab, 2024 (senior author): MeIS: DNA Methylation-Based Immune Response Signatures for Thyroid Nodule Diagnostics. PubMed 38450587
- BMC Med, 2024 (senior author): Blood leukocytes as a non-invasive diagnostic tool for thyroid nodules: a prospective cohort study. PubMed 38561764
- Brachytherapy, 2023 (senior author): Comparison of intraluminal brachytherapy combined with and without stent placement for treatment of obstructive jaundice induced by tumor thrombus. PubMed 37734995
- BMC Gastroenterol, 2023 (senior author): The prognostic role of the AST/ALT ratio in hepatocellular carcinoma patients receiving thermal ablation combined with simultaneous TACE. PubMed 36944920
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion